Dow Down 0.17% Nasdaq Down 0.28%

Actavis plc (ACT)

-NYSE
241.28 Down 3.11(1.27%) Sep 30, 4:01PM EDT
|After Hours : 241.28 0.00 (0.00%) Sep 30, 4:36PM EDT
Prev Close:244.39
Open:244.02
Bid:240.00 x 100
Ask:255.20 x 100
1y Target Est:266.95
Beta:0.35
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:240.06 - 244.53
52wk Range:136.52 - 249.94
Volume:1,666,243
Avg Vol (3m):2,258,380
Market Cap:63.76B
P/E (ttm):633.28
EPS (ttm):0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACTDown 1.27%63.76B
MYLDown 0.66%17.02B
NVSUp 0.61%228.38B
TEVAUp 0.35%45.89B

Key Statistics

Forward P/E (1 yr):14.74
P/S (ttm):6.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :13.28
Quarterly EPS Est (Sep-14) :3.09
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actavis plc, an integrated specialty pharmaceutical company, is engaged in the development, manufacture, marketing, sale, and distribution of pharmaceutical products in the Americas, Europe, the Middle East, Africa, Australia, and the Asia Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback